Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huntington Potter

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Plos One|November 22, 2007
Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALSSvitlana Garbuzova-Davis, Samuel Saporta, Edward Haller, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 15, 2011
Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlatesJohn A Schinka, David A Loewenstein, Ashok Raj, et al.
The Journal of Physiology|January 31, 2026
Intracerebral age-independent reduction of endothelium-dependent hyperpolarization and nitric oxide signalling in the Dp16 mouse model of Down syndromeAbigail N Russell, Danielle A Jeffrey, Gregory Seedorf, et al.
International Journal of Geriatric Psychiatry|May 12, 2020
Neuropsychiatric symptoms as a distinguishing factor between memory diagnosesHillary J Rouse, Brent J Small, John A Schinka, et al.
Journal of Neuroscience Methods|October 2, 2007
Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic miceRalph E Leighty, Melissa J Runfeldt, Donald J Berndt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 11, 2012
Comparing new templates and atlas-based segmentations in the volumetric analysis of brain magnetic resonance images for diagnosing Alzheimer's diseaseQian Shen, Weizhao Zhao, David A Loewenstein, et al.
Free Radical Biology & Medicine|September 9, 2017
Exosomal biomarkers in Down syndrome and Alzheimer's diseaseEric D Hamlett, Aurélie Ledreux, Huntington Potter, et al.
International Journal of Molecular Sciences|April 13, 2024
Specific Binding of Alzheimer's Aβ Peptides to Extracellular VesiclesChristina Coughlan, Jared Lindenberger, Jeffrey G Jacot, et al.
Frontiers in Aging Neuroscience|September 26, 2013
The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjectsRanjan Duara, David A Loewenstein, Qian Shen, et al.
Behavioural Brain Research|June 29, 2004
Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta depositionRalph E Leighty, Lars N G Nilsson, Huntington Potter, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Plos One|November 22, 2007
Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALSSvitlana Garbuzova-Davis, Samuel Saporta, Edward Haller, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 15, 2011
Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlatesJohn A Schinka, David A Loewenstein, Ashok Raj, et al.
The Journal of Physiology|January 31, 2026
Intracerebral age-independent reduction of endothelium-dependent hyperpolarization and nitric oxide signalling in the Dp16 mouse model of Down syndromeAbigail N Russell, Danielle A Jeffrey, Gregory Seedorf, et al.
International Journal of Geriatric Psychiatry|May 12, 2020
Neuropsychiatric symptoms as a distinguishing factor between memory diagnosesHillary J Rouse, Brent J Small, John A Schinka, et al.
Journal of Neuroscience Methods|October 2, 2007
Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic miceRalph E Leighty, Melissa J Runfeldt, Donald J Berndt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 11, 2012
Comparing new templates and atlas-based segmentations in the volumetric analysis of brain magnetic resonance images for diagnosing Alzheimer's diseaseQian Shen, Weizhao Zhao, David A Loewenstein, et al.
Free Radical Biology & Medicine|September 9, 2017
Exosomal biomarkers in Down syndrome and Alzheimer's diseaseEric D Hamlett, Aurélie Ledreux, Huntington Potter, et al.
International Journal of Molecular Sciences|April 13, 2024
Specific Binding of Alzheimer's Aβ Peptides to Extracellular VesiclesChristina Coughlan, Jared Lindenberger, Jeffrey G Jacot, et al.
Frontiers in Aging Neuroscience|September 26, 2013
The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjectsRanjan Duara, David A Loewenstein, Qian Shen, et al.
Behavioural Brain Research|June 29, 2004
Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta depositionRalph E Leighty, Lars N G Nilsson, Huntington Potter, et al.
Pageof 10